References
- Strupp M, Dieterich M, Brandt T. The treatment and natural course of peripheral and central vertigo. Dtsch Arztebl Int 2013;110:505–15.
- Strupp M, Thurtell MJ, Shaikh AG, Brandt T, Zee DS, Leigh RJ. Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus. J Neurol 2011;258:1207–22.
- Brandt T, Zwergal A, Strupp M. Medical treatment of vestibular disorders. Expert Opin Pharmacother 2009;10:1537–48.
- Neuhauser HK. Epidemiology of vertigo. Curr Opin Neurol 2007;20:40–6.
- James AL, Burton MJ. Betahistine for Ménière’s disease or syndrome. Cochrane Database Syst Rev 2001;CD001873.
- Strupp M, Zwergal A, Feil K, Bremova T, Brandt T. Pharmacotherapy of vestibular and cerebellar disorders and downbeat nystagmus: translational and back-translational research. Ann N Y Acad Sci 2015;1343:27–36.
- Stambolieva K, Angov G. Effect of treatment with betahistine dihydrochloride on the postural stability in patients with different duration of benign paroxysmal positional vertigo. Int Tinnitus J 2010;16:32–6.
- Hilton MP, Pinder DK. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev 2014;12:CD003162.
- Frew IJ, Menon GN. Betahistine hydrochloride in Méniére’s disease. Postgrad Med J 1976;52:501–3.
- Lacour M, van de Heyning PH, Novotny M, Tighilet B. Betahistine in the treatment of Ménière’s disease. Neuropsychiatr Dis Treat 2007;3:429–40.
- Nauta JJ. Meta-analysis of clinical studies with betahistine in Ménière’s disease and vestibular vertigo. Eur Arch Otorhinolaryngol 2014;271:887–97.
- Arrang JM, Garbarg M, Quach TT, Dam Trung Tuong M, Yeramian E, Schwartz JC. Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol 1985;111:73–84.
- Gbahou F, Davenas E, Morisset S, Arrang JM. Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo. J Pharmacol ExpTher 2010;334:945–54.
- Botta L, Mira E, Valli S, Zucca G, Benvenuti C, Fossati A, et al. Effects of betahistine and of its metabolites on vestibular sensory organs. Acta Otorhinolaryngol Ital 2001;21(3 Suppl 66):24–30.
- Mira E, Guidetti G, Ghilardi PL, Fattori B, Fattori B, Malannino N, et al. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo. Eur Arch Otorhinolaryngol 2003;260:73–7.
- Della Pepa C, Guidetti G, Eandi M. Betahistine in the treatment of vertiginous syndromes: a meta-analysis. Acta Otorhinolaryngol Ital 2006;26:208–15.
- Guneri EA, Kustutan O. The effects of betahistine in addition to Epley maneuver in posterior canal benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2012;146:104–8.
- Djelilovic-Vranic J, Alajbegovic A, Tiric-Campara M. Betahistine or Cinnarizine for treatment of Ménière’s disease. Med Arch 2012;66:396–8.
- Colletti V. Medical treatment in Ménière’s disease: avoiding vestibular neurectomy and facilitating postoperative compensation. Acta Otolaryngol (Suppl) 2000;544:27–33.
- Ganança MM, Caovilla HH, Ganança FF. Comparable efficacy and tolerability between twice daily and three times daily betahistine for Ménière’s disease. Acta Otolaryngol 2009;129:487–92.